In today's ACT Brief, we explore how FDA evaluates effectiveness for ultra-rare individualized therapies, the agency's ...
1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. News release. FDA. April 13, 2026.
In this video interview, Mwango Kashoki, MD, MPH, senior vice president and global head of regulatory strategy at Parexel, ...
In today's ACT Brief, we examine how protocol interpretation and source document preparation delay study startup, how the ...
A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and ...
In a recent video interview with Applied Clinical Trials, Mwango Kashoki, MD, MPH, senior vice president and global head of ...
In today's ACT Brief, we examine Thermo Fisher's expanded real-world data access through HealthVerity, how FHIR-based ...
In today's ACT Brief, we explore industry perspectives on operational and methodological shifts defining 2026, how agentic AI ...
In a recent video interview with Applied Clinical Trials, Nick Frenzer, general manager of site solutions at Veeva Systems, discussed why eSource has remained c ...
The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
In this Q&A, Krishna Cheriath, VP and head of clinical research digital data and AI at Thermo Fisher Scientific, examines how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results